Patients’ Right to Know Their Medication Act of 2025

Increased Patient Safety: The bill aims to protect patients and prevent costly adverse drug events by providing scientifically accurate and relevant safety information (Section 2, Findings).

Improved Accessibility: By requiring a printed paper format, the bill ensures that patients who cannot access electronic versions of medication information can still receive vital details (Section 2, Findings).

Clearer Communication: The regulations require the use of understandable plain language and the inclusion of graphics or pictures to help patients understand their medications (Section 3(a)(b)(3)(A)).

Standardized Information: Patients will receive consistent information regarding drug names, indications, directions for use, and warnings across different drug products (Section 3(a)(b)(3)(B) and Section 3(a)(b)(4)).

Specific Safety Guidance: The mandated information includes warnings for specific groups like children, pregnant women, and the elderly, as well as information on interactions with food or other drugs (Section 3(a)(b)(4)(D) and Section 3(a)(b)(4)(H)).

Cost Reductions: The mandate for standardized paper information could reduce costs associated with hospital admissions and emergency room visits by an estimated $14.6 to $26.2 billion annually (Section 2, Findings).